Literature DB >> 2532040

abl genes.

L Ramakrishnan1, N Rosenberg.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2532040     DOI： 10.1016/0304-419x(89)90043-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  6 in total

1.  p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.

Authors:  R Dikstein; R Agami; D Heffetz; Y Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.

Authors:  D Cortez; L Kadlec; A M Pendergast
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

3.  Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Authors:  M A Kelliher; J McLaughlin; O N Witte; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.

Authors:  J Y Reuther; G W Reuther; D Cortez; A M Pendergast; A S Baldwin
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

5.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

6.  Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells.

Authors:  Y Honma; J Okabe-Kado; T Kasukabe; M Hozumi; K Umezawa
Journal:  Jpn J Cancer Res       Date:  1990-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.